深圳市第三方检验检测技术服务机构新冠病毒核酸检测能力调查与评估

Investigation and evaluation of COVID-19 nucleic acid detection capability in third-party inspection and testing technology service institutions in Shenzhen City

目的调查、评估深圳市16家第三方检验检测技术服务机构(以下简称第三方机构)的新冠病毒核酸采样、检测能力,发现问题并提出建议,以提高第三方机构新冠病毒核酸检测能力。方法采用问卷调查的方法,对深圳市第三方机构的基本情况、采样能力、检测能力、储备能力等情况进行调查。结果16家第三方机构共有722名工作人员,医学相关专业524人,占72.6%。其中,检验相关专业290人,占40.2%。16家第三方机构中开展采样服务的12家第三方机构日最大采样量为242500管。16家第三方机构日最大检测量为139000管。仅在第三方机构组织采样的情况下,有7家机构采样能力相较于检测能力有溢出的情况。结论第三方机构规模以中小型为主,在新冠肺炎疫情防控中发挥了重要作用,但是存在各机构间能力不均衡、人员配置不合理、未规范培训工作人员等问题,检测能力有待进一步提升。

Objective To investigate and evaluate the sampling and detection capabilities of COVID-19 nucleic acid of16 third-party institutions in Shenzhen City,identify problems and make recommendations to improve COVID-19nucleic acid testing capacity of third-party institutions.Methods Using questionnaire survey method;and investigating the sampling capacity,detection capacity and storage capacity of the third-party institutions in Shenzhen City.Results There were 722 staff in 16 institutions,524 were of medial related majors,accounting for 72.6%.290 were majored in inspection related majors,accounting for 40.2%.The maximum daily sampling volume was 242500 tubes in 12 thirdparty institutions.The maximum daily test volume of 16 third-party institutions was 139000 tubes.Only in the case of third-party institutions’own sampling,there were 7 institutions whose sampling capacity overflowed compared with their detection capacity.Conclusion The scale of third-party institutions is mainly small and medium-sized,and they play an important role in COVID-19 epidemic prevention and control.However,there is imbalance of capabilities among institutions and irrational personnel allocation,and the detection capacity network needs to be further improved.